Urinary biomarkers in children with kidney diseases taking into account obesity
- Authors: Nastausheva T.L.1, Chan A.V.1, Kulakova E.N.1, Volosovets G.G.1, Chichuga E.M.1, Chubarov T.V.1, Gurovich O.V.1, Grebennikova I.V.1
-
Affiliations:
- N.N. Burdenko Voronezh State Medical University
- Issue: Vol 13, No 4 (2022)
- Pages: 65-74
- Section: Original studies
- URL: https://journal-vniispk.ru/pediatr/article/view/114936
- DOI: https://doi.org/10.17816/PED13465-74
- ID: 114936
Cite item
Abstract
BACKGROUND: Overweight and obesity in children are one of the most serious problems of the modern world. There are mane publications devoted to kidney injury in patients with obesity. This injury in developed imperceptibly, without clinical symptoms. Probably the diagnostics of kidney injury in children with obesity may be improved by studying new urinary markers: KIM-1, NGAL, IL-18, β2-mg.
AIM: Aim of our study was the comparative analysis of urinary markers of tubular kidney injury (KIM-1, NGAL, IL-18, β2-mg) in children with obesity and kidney diseases.
MATERIALS AND METHODS: We have been studied 78 children aged 7–15 years: 40 children with different kidney diseases and 38 patients with obesity and kidney diseases. The results of the study were presented as markers concentration in urine and as relation to creatinine (normalized indicators).
RESULTS: In children with obesity and kidney diseases the level of KIM-1 was more high in comparison with the children without obesity. The concentration of other markers (NGAL, IL-18, β2-mg) did not differ in children of two groups. The same results were received when analyzing normalized indicators. It was appeared significant correlation between body mass of patients and NGAL of urine in both groups.
CONCLUSIONS: Investigation of urinary KIM-1 have significance for diagnostics of tubular kidney injury in children with obesity on the background of kidney diseases. Established significant correlation NGAL with body mass can testify about it is diagnostic significance for obesity regardless of kidney diseases.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Tatiana L. Nastausheva
N.N. Burdenko Voronezh State Medical University
Author for correspondence.
Email: nastat53@mail.ru
MD, PhD, Dr. Sci. (Med.), Professor, Head of the Department of Hospital Pediatrics
Russian Federation, VoronezhAnna V. Chan
N.N. Burdenko Voronezh State Medical University
Email: annalijah@mail.ru
Postgraduate Student, Department of Hospital Pediatrics
Russian Federation, VoronezhElena N. Kulakova
N.N. Burdenko Voronezh State Medical University
Email: elena.n.kularova@mail.ru
MD, PhD, Associate Professor, Department of Hospital Pediatrics
Russian Federation, VoronezhGalina G. Volosovets
N.N. Burdenko Voronezh State Medical University
Email: volga-6@mail.ru
MD, PhD, Associate Professor, Department of Hospital Pediatrics
Russian Federation, VoronezhEkaterina M. Chichuga
N.N. Burdenko Voronezh State Medical University
Email: Kagorka@mail.ru
MD, PhD, Associate Professor, Department of Hospital Pediatrics
Russian Federation, VoronezhTimofey V. Chubarov
N.N. Burdenko Voronezh State Medical University
Email: chubarov25@yandex.ru
MD, PhD, Chief of Pediatrics Clinical Hospital
Russian Federation, VoronezhOlga V. Gurovich
N.N. Burdenko Voronezh State Medical University
Email: olgavicg@ya.ru
Associate Professor, Department of Hospital Pediatrics
Russian Federation, VoronezhIrina V. Grebennikova
N.N. Burdenko Voronezh State Medical University
Email: irina_voronezh@inbox.ru
MD, PhD, Associate Professor, Department of Patologic Phisyology
Russian Federation, VoronezhReferences
- Bocharova OV, Teplyakova ED. Children and adolescents’ obesity is the 21st century health problem. Kazan medical journal. 2020;101(3):381–388. (In Russ.) doi: 10.17816/KMJ2020-381
- Vasil’kova ON, Mokhort TV, Filiptsova NA. Uroven’ neitrofil’nogo lipokalina v moche u patsientov s sakharnym diabetom i khronicheskoi bolezn’yu pochek. Healthcare. 2014;(11):20–23. (In Russ.)
- Vyalkova AA, Lebedeva EN, Afonina SN, et al. Kidney diseases and obesity: molecular relationship and new approaches to diagnosis (literature review). Nephrology (Saint-Petersburg). 2017;21(3):25–38. (In Russ.) doi: 10.24884/1561-6274-2017-3-25-38
- Zhezha VV, Kuzmin OB, Libis RA, Gorbunova NP. Applying of urine biomarkers NGAL and KIM-1 for early detection of renal proximal tubular damage in patients with arterial hypertension. Nephrology (Saint-Petersburg). 2017;21(5):53–58. (In Russ.) doi: 10.24884/1561-6274-2017-21-5-64-75
- Eremeeva AV, Dlin VV, Korsunsky AA, et al. Clinical significance of determination of lipocalin-2 associated with neutrophilic gelatinase in patients with chronic kidney disease (literature review). Nephrology (Saint-Petersburg). 2018;22(4):50–56. (In Russ.) doi: 10.24884/1561-6274-2018-22-4-50-56
- Parvan MA, Nikolaev AYu, Vokuev IA, Khorobrykh VV. Lipokalin-2 — rannii biomarker ostrogo povrezhdeniya pochek. Lechaschi vrach. 2013;(1):45–49. (In Russ.)
- Smirnowa NN, Galkina OV, Novikova VP, Prokopyeva NE. Modern biomarkers of renal damage in pediatrics. Nephrology (Saint-Petersburg). 2019;23(4):112–118. (In Russ.) doi: 10.24884/1561-6274-2019-23-4-112-118
- Smirnova NN, Kuprienko NB. Diabetic nephropathy in pediatrics. Nephrology (Saint-Petersburg). 2013;17(6):37–45. (In Russ.) doi: 10.24884/1561-6274-2013-17-6-37-45
- Bagshaw SM. Novel biomarkers for early diagnosis of acute kidney injury. Expert Opin Med Diagn. 2008;2(9): 1041–1054. doi: 10.1517/17530059.2.9.1041
- Chen J, Gu D, Chen C-S, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant. 2007;22(4):1100–1106. doi: 10.1093/ndt/gfl759
- Ding W, Mak RH. Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2015;30(1):1–4. doi: 10.1007/s00467-014-2976-3
- Freemark M, editor. Pediatric Obesity: Etiology, Pathogenesis and Treatment. New York: Humana Press, 2010. P. 27–30. doi: 10.1007/978-1-60327-874-4
- Mount PF, Juncos LA. Obesity-related CKD: When Kidneys Get the Munchies. J Am Soc Nephrol. 2017;28(12): 3429–3432. doi: 10.1681/ASN.2017080850
- Nastausheva TL, Nastausheva NS, Chubarov TV, et al. Influence of obesity on course of chronic kidney disease in children. Pediatr Nephrol. 2019;34(10):1982–1983.
- Orsi CM, Hale DE, Lyncj JL. Pediatric obesity epidemiology. Curr Opin Endocrinol Diabetes Obes. 2011;18(1): 14–20. doi: 10.1097/MED.0b013e3283423de1
- Patel ML, Sachan R, Verma A, et al. Neutrophil gelatinase associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease. Indian J Nephrol. 2016;26(2):125–130. doi: 10.4103/0971-4065.157799
- Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–1843. doi: 10.2215/CJN.01640309
- Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol. 2006;21(4):463–470. doi: 10.1007/s00467-006-0027-4
- Teplan V Jr, Vyhnanek F, Gurlich R, et al. Increased proin-flammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr. 2010;122:466–473. doi: 10.1007/s00508-010-1409-y
- Vim HE, Voo KH. Early life obesity and chronic kidney disease in later life. Pediatr Nephrol. 2015;30(8): 1255–1263. doi: 10.1007/s00467-014-2922-4
- Waanders F, Timmeren MM, Stegeman CA, et al. Kidney injury molecule-1 in renal disease. J Pathol. 2010;220(1):7–16. doi: 10.1002/path.2642
- www.who.int [Internet]. WHO AnthroPlus software. WHO growth reference 5–19 years. Application tools [cited 2021 Aug 10]. Available at: http://www.who.int/growthref/tools/en/
Supplementary files
